Site Under Construction

Subungual squamous cell carcinoma of the great toe presenting as a pyogenic granuloma-like mass in a 64-year-old Filipino male: a case report

Sher Claranza O. Liquido, MD, Bernice C. Navarro, MD, FPSGS, FPCS, Tanya Angela Perez Chua, MD, FPDS, Mae Ramirez Quizon, MD, FPDS

Abstract

Introduction

Subungual squamous cell carcinoma is rare, though it is the most common primary malignant neoplasm in the nail unit. Fingernails are more commonly involved than toenails with nonspecific and mild features. Histopathologic presentation may be difficult to distinguish from other tumors. With this, there is often a delay in diagnosis.

 

Case Report

A 64-year-old male presented with a subungual yellowish granulomatous plaque, eventual dystrophy, and persistent bleeding on the fi rst digit of the right foot of two years’ duration. Initially diagnosed as pyogenic granuloma through skin punch biopsy, debridement with ungiectomy was done. Upon recurrence, he underwent wide excision with matricectomy, wherein deeper sections revealed features of basosquamous carcinoma. A positive Epithelial Membrane Antigen and negative BerEP4 staining later confi rmed a diagnosis of SCC. Since bone involvement was repeatedly suspected in magnetic resonance imaging after postoperative radiotherapy, amputation was eventually done.

 

Conclusion

We report a case of subungual SCC initially diagnosed as a pyogenic granuloma. Full-thickness biopsy should be done in persistent nail conditions using special stains to confirm the diagnosis. Surgical treatment or radiotherapy with or without systemic therapy is the first line of treatment for subungual SCC. In cases of bone involvement, amputation may be warranted.

References

  1. Lonsdorf AS, Hadaschik EN. Squamous Cell Carcinoma and Keratoacanthoma. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS, editors. Fitzpatrick’s Dermatology in General Medicine. McGraw Hill; 2019. Vol 1; p. 1901-16.
  2. Dalle S, Depape L, Phan A, Balme B, Ronger-Savle S, Thomas L. Squamous cell carcinoma of the nail apparatus: clinicopathological study of 35 cases. Br J Dermatol. 2007 May;156(5):871-4. DOI: 10.1111/j.1365-2133.2006.07744.x
  3. Dijksterhuis A, Friedeman E, Heijden BVD. Squamous Cell Carcinoma of the Nail Unit: Review of the Literature. J Hand Surg Am. 2018;43(4). DOI:10.1016/j.jhsa.2018.01.010.
  4. Khullar G, Singh S, Saikia UN, Kumar A, Singh MP, Kanwar AJ. Squamous cell carcinoma of the nail fold masquerading as pyogenic granuloma. Indian J Dermatol Venereol Leprol 2016;82:555-557. DOI: 10.4103/0378-6323.182975.
  5. Murad A, Armstrong A, Baum C, Bordeaux JS, Brown M, Busam KJ, et al. Guidelines of care for the management of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2018;78:560-78. DOI: 10.1016/j.jaad.2017.10.007.
  6. Patterson JW. Tumors of the Epidermis. In: Patterson JW, editor. Weedon’s Skin Pathology. Charlottesville, VA: Churchill Livingston; 2016:815-21.
  7. Beer TW, Shepherd P, Theaker JM. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology. 2000;37(3):218-23. DOI:10.1046/j.1365-2559.2000.00999.x.
  8. Heyderman E, Graham RM, Chapman DV, Richardson TC, Mckee PH. Epithelial markers in primary skin cancer: an immunoperoxidase study of the distribution of epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA) in 65 primary skin carcinomas. Histopathology. 1984;8(3):423-434. DOI:10.1111/j.1365-2559.1984.tb02354.x.
  9. National Comprehensive Cancer Network [Internet]. Squamous Cell Skin Cancer (Version 2.2018) [cited 2020 Jan 6]. Available from: http://www.nccn.org.
  10. Starace M, Alessandrini A, Dika E, Piraccini BM. Squamous cell carcinoma of the nail unit. Dermatol Pract Concept. 2018;8(3):238-44. DOI:10.5826/dpc.0803a017.49

REquesting Permission

Subungual squamous cell carcinoma of the great toe presenting as a pyogenic granuloma-like mass in a 64-year-old Filipino male: a case report